Long-term efficacy and downstream mechanism of anti-annexinA2 monoclonal antibody (anti-ANX A2 mAb) in a pre-clinical model of aggressive human breast cancer
Keyword(s):
2016 ◽
Keyword(s):
2000 ◽
2003 ◽
Vol 66
(5)
◽
pp. 831-840
◽
Keyword(s):
2001 ◽
Vol 276
(43)
◽
pp. 40080-40086
◽
1991 ◽
Vol 27
(1)
◽
pp. 48-50
◽
Keyword(s):
2014 ◽
Vol 59
(3)
◽
pp. 413-423
◽
1985 ◽
Vol 82
(14)
◽
pp. 4803-4807
◽
2012 ◽
Vol 109
(22)
◽
pp. 8699-8704
◽
Keyword(s):